Form 4: HCA Healthcare Executive Acquires Stock Appreciation Rights

HCA Healthcare's Executive Vice President and COO, Jon M. Foster, was granted 16,756 stock appreciation rights on January 28, 2025.

Summary

• Jon M. Foster, Executive Vice President and COO of HCA Healthcare, acquired 16,756 stock appreciation rights on January 28, 2025.
• These rights are exercisable for common stock and vest in four equal annual installments starting January 28, 2026.
• The stock appreciation rights expire on January 28, 2035.

Sentiment

Score: 7

Explanation: The document reflects a routine executive compensation transaction, which is generally viewed positively as it aligns management interests with shareholders. There are no negative implications.

Positives

• The grant of stock appreciation rights aligns the executive's interests with those of the shareholders.
• The vesting schedule encourages long-term performance and retention of the executive.

Industry Context

The granting of stock appreciation rights is a common practice in executive compensation packages within the healthcare industry, aligning executive interests with company performance and shareholder value.

Comparison to Industry Standards

• Stock appreciation rights are a common form of equity compensation used by companies like Tenet Healthcare and Universal Health Services to incentivize their executives.
• The vesting schedule of four equal annual installments is also a standard practice in the industry, similar to what is seen in executive compensation plans at Community Health Systems.

Stakeholder Impact

• The granting of stock appreciation rights is intended to align the executive's interests with those of the shareholders, potentially leading to increased shareholder value.

Key Dates

Keywords

stock appreciation rights, HCA Healthcare, executive compensation, insider trading, Form 4, Jon M. Foster